Evidence map›Paper›PMID 38280439›Full record

SynthesisJournal of pain and symptom management2024

Criteria for Enrollment of Patients With COPD in Palliative Care Trials: A Systematic Review.

Natalia Smirnova, Allison V Lange, Amanda Glickman, Kristen Desanto, Cara L McDermott, Donald R Sullivan, David B Bekelman, Dio Kavalieratos

Open access · bronzeAbstract readSystematic Review
In one paragraph

Synthesis in Journal of pain and symptom management, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 1 country.

Natalia SmirnovaDivision of Pulmonary, Allergy and Critical Care Medicine (N.S.), Emory University School of Medicine, Atlanta, Georgia, USA.
Allison V LangeDivision of Pulmonary Sciences and Critical Care Medicine (A.V.L.), University of Colorado School of Medicine, Aurora, Colorado, USA. Electronic address: Allison.lange@cuanschutz.edu.
Amanda GlickmanDivision of General Internal Medicine (A.G., D.B.B.), University of Colorado School of Medicine, Aurora, Colorado, USA.
Kristen DesantoStrauss Health Sciences Library (K.D.), University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Cara L McDermottDivision of Geriatrics (C.L.M.), Duke University School of Medicine, Durham, North Carolina, USA.
Donald R SullivanDivision of Pulmonary, Allergy and Critical Care Medicine (D.R.S.), Oregon Health and Science University, Portland, Oregon, USA; Center to Improve Veteran Involvement in their Care (CIVIC) (D.R.S.), VA Portland Health Care System, Portland, Oregon, USA; Knight Cancer Institute (D.R.S.), Oregon Health and Science University, Portland, Oregon, USA.
David B BekelmanDivision of General Internal Medicine (A.G., D.B.B.), University of Colorado School of Medicine, Aurora, Colorado, USA; Department of Medicine, Eastern Colorado Health Care System, Department of Veterans Affairs (D.B.B.), Denver, Aurora, Colorado, USA.
Dio KavalieratosDivision of Palliative Medicine (D.K.), Emory University School of Medicine, Atlanta, Georgia, USA; Rollins School of Public Health (D.K.), Emory University, Atlanta, Georgia, USA.
Emory University · USUniversity of Colorado Denver · USDuke University · USOregon Health & Science University · USUniversity of Colorado Anschutz Medical Campus · USVA Eastern Colorado Health Care System · US

Funding

Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE)UL1TR002378 · NCATS · EMORY UNIVERSITY · PI Andres J Garcia, Elizabeth O. Ofili · 2017 to 2026
$92.1M
The Emory Training Program in Lung HealthT32HL116271 · NHLBI · EMORY UNIVERSITY · PI BROWN, LOU ANN S, GUIDOT, DAVID MARSHALL · 2013 to 2022
$4.2M
Mid-Career Mentoring Award in Palliative Care, Aging, and Cognitive ImpairmentK24AG070322 · NIA · UNIVERSITY OF COLORADO DENVER · PI David B. Bekelman · 2022 to 2026
$930k
Reducing Polypharmacy and Fall Risk for Multi-Morbid Adults with Chronic Obstructive Pulmonary DiseaseK23HL159239 · NHLBI · DUKE UNIVERSITY · PI MCDERMOTT, CARA LYN · 2022 to 2025
$724k
Uncertainty Among Patients Undergoing Lung Transplant EvaluationF32HL168977 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI LANGE, ALLISON V · 2023 to 2023
$88k
Palliative Care to Improve Quality of Life in CHF and COPDI01HX001770 · VA · VA EASTERN COLORADO HEALTH CARE SYSTEM · PI BEKELMAN, DAVID B. · 2019 to 2019
–
HSRD VA I01 HX001770NCATS NIH HHS UL1 TR002378NHLBI NIH HHS F32 HL168977NHLBI NIH HHS K23 HL159239NHLBI NIH HHS T32 HL116271NIA NIH HHS K24 AG070322
6 · The paper itself

Abstract

contextUse of palliative care interventions in chronic obstructive pulmonary disease (COPD) has increased in recent years and inclusion criteria used to identify patients with COPD appropriate for palliative care vary widely. We evaluated the inclusion criteria to identify ways to improve enrollment opportunities for patients with COPD.

objectivesTo determine inclusion criteria used to select patients with COPD for palliative care trials.

methodsA systematic review was conducted to determine criteria used to select patients with COPD for palliative care randomized controlled trials. A narrative synthesis was conducted for all trials.

resultsInclusion criteria were highly heterogeneous. Most studies (n = 11, 79%) used a combination of criteria to identify patients with COPD. Commonly used criteria included hospitalization for an acute exacerbation of COPD (n = 8, 57%), home supplemental oxygen use (n = 8, 57%), and spirometry values confirming COPD (n = 6, 43%). Three studies (21.4%) used Modified Medical Research Council score and two studies (21%) used physician prognosis or a performance scale.

conclusionThe most common criteria, a hospitalization for acute exacerbation of COPD or supplemental oxygen use at home, both have the benefit of selecting patients who have a higher symptom burden or higher healthcare utilization who might therefore benefit more from palliative care. By describing the landscape and variability of previously used inclusion criteria, this article serves as a resource for clinicians and researchers. Developing a consistent set of inclusion criteria in the future would help generate generalizable results that can be translated into clinical practice to improve the lives of patients with COPD. PROSPERO REGISTRATION NUMBER: CRD42022306752.

Indexed as

Palliative CarePatient SelectionPulmonary Disease, Chronic ObstructiveRandomized Controlled Trials as TopicHumansChronic obstructive pulmonary disease (COPD)palliative care

Identifiers

PMID38280439
PMCPMC11088983
OpenAlexW4391248373

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.